Jeffrey W. Albers - Mar 1, 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 06:58 PM
Previous filing
Nov 17, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Award $0 +7.5K +3.98% $0.00 196K Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Award $0 +15K $0.00 15K Mar 1, 2022 Common Stock 15K $61.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a grant of 7,500 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
F2 This option vests with respect to 1/48th of the shares underlying the option on April 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter.